Results for tag: "Cymarin"

The Cymarin market is a segment of the cardiovascular drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. These drugs are used to treat a variety of conditions, including high blood pressure, coronary artery disease, congestive heart failure, and arrhythmias. Cymarin drugs are a class of drugs used to treat arrhythmias, which are abnormal heart rhythms. These drugs work by blocking certain electrical signals in the heart, which can help to restore a normal heart rhythm. The Cymarin market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Bayer. Show Less Read more